25 November 2024
Financial Summary As at 30th September 2024 NAV per share 388.5p Total Assets £466.2m Ordinary shares Share price 227.0p Discount 41.6% Gross Yield 1.4%…
Truqap combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progression-free survival in CAPItello-281 Phase III trial First and only…
Blenrep combinations accepted for review by the US FDA for the treatment of relapsed/refractory multiple myeloma · Regulatory submission supported by phase III head-to-head DREAMM-7 and…
22 November 2024
FW Thorpe Plc Annual General Meeting statement At the Annual General Meeting of FW Thorpe Plc, held at 3.15pm 21 November 2024, Chairman, Mike…
Michelmersh Brick Holdings Plc (“MBH“, the “Company“, or the “Group“) Pre-Close Trading Update and Notice of Results Resilient performance, trading in line with market expectations …
Games Workshop Group PLC (the “Company”) TRADING UPDATE The Group is pleased to announce that trading since the last update on 18 September 2024…
21 November 2024
SANTA CLARA, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) — NVIDIA (NASDAQ: NVDA) today reported revenue for the third quarter ended October 27, 2024, of…
Jet2 plc Interim Results for the half year ended 30 September 2024 Another record performance with full year outlook upgraded Group financial highlights (unaudited) HY25…